Advertisement

Does chronic low molecular weight heparins use during pregnancy increase the risk of postpartum hemorrhage?

Published:December 17, 2022DOI:https://doi.org/10.1016/j.thromres.2022.12.009
      Postpartum hemorrhage (PPH) continues to be the leading preventable cause of maternal morbidity and mortality worldwide. Although many risk factors have been identified, this life-threatening complication often occurs in women who have no clear identifiable risk factors [
      • Kramer M.S.
      • Berg C.
      • Abenhaim H.
      • Dahhou M.
      • Rouleau J.
      • Mehrabadi A.
      • Joseph K.S.
      Incidence, risk factors, and temporal trends in severe postpartum hemorrhage.
      ].

      Abbreviations:

      ART (assisted reproductive technologies), BMI (body mass index), CI (confidence interval), CS (caesarean section), IQR (interquartile range), LMWHs (low-molecular-weight heparins), PPH (postpartum hemorrhage), RR (relative risk), VTE (venous thrombo-embolism), WHO (World Health Organization), aRR (adjusted relative risk)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kramer M.S.
        • Berg C.
        • Abenhaim H.
        • Dahhou M.
        • Rouleau J.
        • Mehrabadi A.
        • Joseph K.S.
        Incidence, risk factors, and temporal trends in severe postpartum hemorrhage.
        Am. J. Obstet. Gynecol. 2013 Nov; 209: 449.e1-449.e7https://doi.org/10.1016/j.ajog.2013.07.007
        • Zullino S.
        • Clemenza S.
        • Mecacci F.
        • Petraglia F.
        Low molecular weight heparins (LMWH) and implications along pregnancy: a focus on the placenta.
        Reprod. Sci. 2021 Jul 6; https://doi.org/10.1007/s43032-021-00678-0
        • Sirico A.
        • Saccone G.
        • Maruotti G.M.
        • Grandone E.
        • Sarno L.
        • Berghella V.
        • Zullo F.
        • Martinelli P.
        Low molecular weight heparin use during pregnancy and risk of postpartum hemorrhage: a systematic review and meta-analysis.
        J. Matern. Fetal Neonatal Med. 2019 Jun; 32: 1893-1900https://doi.org/10.1080/14767058.2017.1419179
        • Knol H.M.
        • Schultinge L.
        • Veeger N.J.
        • Kluin-Nelemans H.C.
        • Erwich J.J.
        • Meijer K.
        The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy.
        Thromb. Res. 2012 Sep; 130: 334-338https://doi.org/10.1016/j.thromres.2012.03.007
        • Wang E.H.
        • Marnoch C.A.
        • Khurana R.
        • Sia W.
        • Yuksel N.
        Haemorrhagic complications of peripartum anticoagulation: a retrospective chart review.
        Obstet. Med. 2014 Jun; 7: 77-83https://doi.org/10.1177/1753495X14520849
        • Maslovitz S.
        • Many A.
        • Landsberg J.A.
        • Varon D.
        • Lessing J.B.
        • Kupferminc M.J.
        The safety of low molecular weight heparin therapy during labor.
        J. Matern. Fetal Neonatal Med. 2005 Jan; 17: 39-43https://doi.org/10.1080/14767050400028626
        • Kominiarek M.A.
        • Angelopoulos S.M.
        • Shapiro N.L.
        • Studee L.
        • Nutescu E.A.
        • Hibbard J.U.
        Low-molecular-weight heparin in pregnancy: peripartum bleeding complications.
        J. Perinatol. 2007 Jun; 27: 329-334https://doi.org/10.1038/sj.jp.7211745
        • Freedman R.A.
        • Bauer K.A.
        • Neuberg D.S.
        • Zwicker J.I.
        Timing of postpartum enoxaparin administration and severe postpartum hemorrhage.
        Blood Coagul. Fibrinolysis. 2008 Jan; 19: 55-59https://doi.org/10.1097/MBC.0b013e3282f185dd
        • Arbuthnot C.
        • Browne R.
        • Nicole S.
        • Erb S.J.
        • Farrall L.
        • Borg A.
        A double centre retrospective study into rates of postpartum haemorrhage in women on low molecular weight heparin.
        Br. J. Haematol. 2017 Jan; 176: 141-143https://doi.org/10.1111/bjh.13939
        • Roshani S.
        • Cohn D.M.
        • Stehouwer A.C.
        • Wolf H.
        • van der Post J.A.
        • Büller H.R.
        • Kamphuisen P.W.
        • Middeldorp S.
        Incidence of postpartum haemorrhage in women receiving therapeutic doses of low-molecular-weight heparin: results of a retrospective cohort study.
        BMJ Open. 2011 Nov 14; 1e000257https://doi.org/10.1136/bmjopen-2011-000257
        • Omotayo M.O.
        • Abioye A.I.
        • Kuyebi M.
        • Eke A.C.
        Prenatal anemia and postpartum hemorrhage risk: a systematic review and meta-analysis.
        J. Obstet. Gynaecol. Res. 2021 Aug; 47: 2565-2576https://doi.org/10.1111/jog.14834
        • Adebiyi A.
        • Adaikan G.P.
        • Prasad R.N.
        Oxytocic activity of thrombin: modulation of thrombin-induced gravid rat myometrial contractions by 5-hydroxytryptamine receptor antagonists.
        J. Perinat. Med. 2004; 32: 126-131https://doi.org/10.1515/JPM.2004.023
        • Elovitz M.A.
        • Saunders T.
        • Ascher-Landsberg J.
        • Phillippe M.
        Effects of thrombin on myometrial contractions in vitro and in vivo.
        Am. J. Obstet. Gynecol. 2000 Oct; 183: 799-804https://doi.org/10.1067/mob.2000.108897
        • Nishimura F.
        • Mogami H.
        • Moriuchi K.
        • Chigusa Y.
        • Mandai M.
        • Kondoh E.
        Mechanisms of thrombin-induced myometrial contractions: potential targets of progesterone.
        PLoS One. 2020 May 4; 15e0231944https://doi.org/10.1371/journal.pone.0231944
        • McLean K.C.
        • Bernstein I.M.
        • Brummel-Ziedins K.E.
        Tissue factor-dependent thrombin generation across pregnancy.
        Am. J. Obstet. Gynecol. 2012 Aug; 207: 135.e1-135.e6https://doi.org/10.1016/j.ajog.2012.05.027